Navigation Links
Endo Pharmaceuticals Announces Receipt of Paragraph IV Certification
Date:1/19/2010

CHADDS FORD, Pa., Jan. 19 /PRNewswire-FirstCall/ -- Endo Pharmaceuticals (Nasdaq: ENDP) announced today that its partners, Teikoku Seiyaku Co., Ltd. and Teikoku Pharma USA, Inc. have received a Paragraph IV Certification Notice from Watson Laboratories, Inc. advising of the filing of an Abbreviated New Drug Application (ANDA) for a generic version of LIDODERM® (lidocaine topical patch 5%).

The company is currently reviewing the details of this notice from Watson.  Endo intends to vigorously defend LIDODERM's intellectual property rights and pursue all available legal and regulatory pathways in defense of LIDODERM.  

The Paragraph IV certification notice refers to U.S. Patent No. 5,827,529, which covers the formulation of LIDODERM, a topical patch to relieve the pain of postherpetic neuralgia launched in 1999. This patent is listed in the U.S. Food and Drug Administration's (FDA) Orange Book and expires in October 2015.

Citizen Petition

With respect to Endo's regulatory approach, the company submitted a Citizen Petition in 2006 in reaction to a proposal by FDA's Office of Generic Drugs that would diverge from applicable regulations and standards of practice regarding bioequivalence. The company is requesting that the agency reconsider its departure from its longstanding general rule of requiring clinical endpoint bioequivalence studies for locally acting generic drug products, including those that reference LIDODERM.  To ensure the safe and effective equivalence of any generic version to LIDODERM, which acts locally in the skin, Endo believes that FDA must return to its established standard of clinical endpoint bioeq
'/>"/>

SOURCE Endo Pharmaceuticals
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
2. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
3. Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals Announce Receipt of an FDA Action Letter for Bifeprunox, an Investigational Treatment for Schizophrenia
4. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
5. WallSt.net (www.wallst.net) Updates the Investment Community Through an All-New Interview With RegeneRx Biopharmaceuticals CEO
6. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
7. Peregrine Pharmaceuticals Doses First Patient in Cotara(R) Phase II Brain Cancer Trial In India
8. Nabi Biopharmaceuticals Announces Second Quarter 2007 Financial Results
9. Access Pharmaceuticals Provides Update on Clinical Development Plan of ProLindac
10. Quark Pharmaceuticals Extends Research Agreement with State University of New York for Proprietary siRNA Compounds for Acute Hearing Loss
11. Acura Pharmaceuticals, Inc. Secures Financing to Fund Pivotal Phase III Clinical Trial for Lead Aversion(R) Technology Product Candidate
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/27/2014)... , Aug. 27, 2014  Decision Resources ... specialties (medical oncology, hematology-oncology, rheumatology, gastroenterology, endocrinology and ... trials that a biosimilar has been assessed in ... product they choose to prescribe. ... report entitled Acceptance of Biosimilars Across ...
(Date:8/27/2014)... -- According to the new research ... Chairs, Dental Lasers), Current Trends, Opportunities - Global Forecast ... Market is expected to reach $7,138.9 million by ... a CAGR of 5.7% between 2014 and 2019. ... 61 figures spread through 167 pages and in-depth ...
(Date:8/27/2014)... , Aug. 27, 2014 Reportlinker.com announces ... in its catalogue: Global Heart Valve ... http://www.reportlinker.com/p02316644/Global-Heart-Valve-Repair-and-Replacement-Market-2014-2018.html About Heart Valve ... the human heart which control the flow of ... with heart valve diseases such as valvular stenosis, ...
Breaking Medicine Technology:Surveyed Physicians Expect to Choose Between Future Biosimilars Based on Robustness and Number of Clinical Trials 2Dental Equipment Market Worth $7,138.9 Million by 2019 2Dental Equipment Market Worth $7,138.9 Million by 2019 3Global Heart Valve Repair and Replacement Market 2014-2018 2Global Heart Valve Repair and Replacement Market 2014-2018 3Global Heart Valve Repair and Replacement Market 2014-2018 4
(Date:8/28/2014)... 2014 MMAR Medical is pleased to ... chance for regular customers to enjoy several perks and ... for a wholesale license. It’s a great choice for ... and others who regularly purchase medical braces but could ... your own active lifestyle or those of your club, ...
(Date:8/28/2014)... 28, 2014 On September 1st, the ... Back-to-School campaign. The goal is to help families ... calmly and effectively and without exposures to risky pesticides. ... agree: “Children’s exposures to pesticides should be limited ... , Head lice are often trivialized in the media, ...
(Date:8/27/2014)... Missouri (PRWEB) August 28, 2014 A ... Carey Danis & Lowe reports that the C.R. ... of thousands of consolidated transvaginal mesh lawsuits, recently filed ... PTO #136 pertains to the pretrial discovery process, and ... physically sensitive evidence. , Carey Danis & Lowe is ...
(Date:8/27/2014)... FL (PRWEB) August 27, 2014 ... money-saving dental plans, has launched in the state ... access to quality, affordable dental care services at ... destination for Tennessee consumers looking to save money ... dental rates as a member of discount fee ...
(Date:8/27/2014)... (PRWEB) August 28, 2014 For ... and XML websites, ASP.NET hosting products are very ... ), Arvixe, and FatCow are the best ASP.NET ... has been known as a top web hosting ... for reliability remains with it today. Recently proclaimed ...
Breaking Medicine News(10 mins):Health News:MMAR Medical Announces Customer Membership Program 2Health News:Head Lice Can Be a Public Health Opportunity 2Health News:Head Lice Can Be a Public Health Opportunity 3Health News:Head Lice Can Be a Public Health Opportunity 4Health News:Carey Danis & Lowe Reports On New Court Order in C.R. Bard Transvaginal Mesh MDL 2Health News:DentistSave.com Launches Discount Dental Plans in Tennessee for Consumers, Businesses, and Groups 2Health News:DentistSave.com Launches Discount Dental Plans in Tennessee for Consumers, Businesses, and Groups 3Health News:Top10BestSEOHosting.com Releases the Best ASP.NET Hosting Suppliers of This Year: Hostgator, Arvixe and FatCow 2
... and Medical Center, Phoenix, today announced the signing of ... for the deployment of the company,s state-of-the-art videoconferencing ... be used to connect specialist physicians at the hospital ... will include the Barrow Neurological Institute, as well as ...
... Essential survival gear for parents and guardians raising girls ... Changes (TM) is the leading product to help ... . (Photo: http://www.newscom.com/cgi-bin/prnh/20090512/LA13991 ) WHO: ... are Tara Harrington and Susanne Marcotte-Carroll, two ...
... percent lower in those who take supplements that long, research ... for at least a year before conception, folic acid supplements ... at least 50 percent, University of Texas researchers say. , ... PLoS Medicine , found no link to a reduction in ...
... who has developed a pioneering technique using microwaves to destroy ... UK and other patients are now being treated internationally. ... year die of primary liver cancer, with another million dying ... other tumour sites such as cancer of the colon. ...
... 2009) When Americans were asked to value the ... as they consider spending their own money, they chose ... revealed. , The Spectrum Health Value Study, the first ... representative sample of Americans over the past six months ...
... Human monoclonal antibodies effective against bird and seasonal ... colleagues, working with researchers at the Dana-Farber Cancer ... Prevention, reported the identification of human monoclonal antibodies ... viruses, including avian influenza A (H5N1) virus, previous ...
Cached Medicine News:Health News:St. Joseph's Hospital and Medical Center Signs Agreement for Innovative Video Conferencing Use 2Health News:Changes(TM) Kit for Girls - 'What Every Girl Wants.' 2Health News:Worldwide success in treatment of liver tumors 2Health News:Worldwide success in treatment of liver tumors 3Health News:Access to care leads Americans' priorities in first-ever public study of health value 2Health News:Recent developments at Burnham Institute for Medical Research, May 2009 2Health News:Recent developments at Burnham Institute for Medical Research, May 2009 3Health News:Recent developments at Burnham Institute for Medical Research, May 2009 4Health News:Recent developments at Burnham Institute for Medical Research, May 2009 5
... mm applier contains 20 titanium clips in the ... in the L size. The appliers are designed ... Auto Suture trocar sleeves, or larger sized trocar ... introduction of the ENDO CLIP clip applier through ...
... The Tissue Lock Clip is designed with ... superior on-vessel clip retention and improved hemostasis., ... design has a 20 percent greater angle ... placement., ,The Reflex® ELC has an ...
Insert only, Pilling-Weck small clip size...
Insert only, Ethicon, medium clip size...
Medicine Products: